EURONEXT:ABNX
ABIONYX Pharma SA
- Stock
Last Close
1.28
30/08 15:14
Market Cap
39.38M
Beta: 0.27
Volume Today
6.31K
Avg: 123.73K
PE Ratio
−7.77
PFCF: −10.89
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -7.74M - | -6.56M 15.23% | -16.64M 153.51% | -24.87M 49.48% | -4.98M 79.98% | -6.30M 26.66% | 1.85M 129.33% | -1.89M 202.00% | -5.82M 208.70% | -4.21M 27.76% | -3.50M 16.79% | |
depreciation and amortization | 156K - | 88K 43.59% | 56K 36.36% | 48K 14.29% | 43K 10.42% | 39K 9.30% | 13K 66.67% | 22K 69.23% | 119K 440.91% | 135K 13.45% | ||
deferred income tax | 18K - | 495K 2,650% | -222K 144.85% | -296K 33.33% | -1.10M 270.61% | 1.19M 208.11% | -4.96M 517.96% | -98K 98.02% | -815K 731.63% | |||
stock based compensation | 970K - | 369K 61.96% | 511K 38.48% | 5.40M 956.36% | -731K 113.54% | 33K 104.51% | 98K 196.97% | 98K 0% | 815K 731.63% | 506K 37.91% | ||
change in working capital | -5.96M - | 1.62M 127.15% | 1.23M 24.03% | -733K 159.59% | -895K 22.10% | -316K 64.69% | -1.30M 312.66% | 2.13M 263.34% | -1.74M 181.88% | 97K 105.56% | ||
accounts receivables | -95K - | 36K 137.89% | ||||||||||
inventory | 6K - | 30K 400% | ||||||||||
accounts payables | -837K - | 1.22M 245.16% | 95K 92.18% | -36K 137.89% | ||||||||
other working capital | -467K - | 915K 295.93% | -1.75M 291.26% | 67K 103.83% | ||||||||
other non cash items | -1.91M - | 1.18M 161.86% | 1.13M 4.56% | 961K 14.96% | -2.53M 363.37% | -638K 74.79% | 351K 155.02% | -865K 346.44% | 755K 187.28% | 109K 85.56% | -200K 283.49% | |
net cash provided by operating activities | -14.49M - | -3.30M 77.21% | -13.71M 315.11% | -19.20M 40.01% | -9.09M 52.64% | -6.00M 34.00% | -3.95M 34.18% | -599K 84.84% | -6.69M 1,017.20% | -3.36M 49.81% | -3.70M 10.15% | |
investments in property plant and equipment | -8K - | -3K 62.50% | -171K 5,600% | -5K 97.08% | -213K 4,160% | -23K 89.20% | -148K - | -166K 12.16% | -175K 5.42% | |||
acquisitions net | 23K - | 1.50M 6,439.13% | ||||||||||
purchases of investments | ||||||||||||
sales maturities of investments | ||||||||||||
other investing activites | 4K - | -10K 350% | 13K - | -100K - | ||||||||
net cash used for investing activites | -8K - | 1K 112.50% | -171K 17,200% | -5K 97.08% | -213K 4,160% | -10K 95.31% | -125K - | 1.34M 1,170.40% | -175K 113.08% | -100K 42.86% | ||
debt repayment | -750K - | -400K - | -200K 50% | -19K 90.50% | -236K 1,142.11% | |||||||
common stock issued | 49.48M - | 925K 98.13% | 152K 83.57% | 1.20M 686.18% | 973K 18.58% | 1.84M 88.69% | 4.06M 120.92% | 42K 98.96% | ||||
common stock repurchased | -485K - | -89K - | -65K 26.97% | |||||||||
dividends paid | -1.55M - | -3.97M 156.76% | ||||||||||
other financing activites | 750K - | 250K - | 1.55M 518.80% | 3.97M 156.76% | 3.90M - | |||||||
net cash used provided by financing activities | -750K - | 48.99M - | 925K 98.11% | 902K 2.49% | 1.20M 32.48% | 823K 31.13% | 1.55M 87.97% | 3.97M 156.76% | -194K 104.88% | 3.90M 2,110.31% | ||
effect of forex changes on cash | -2K - | 4K 300% | -2K 150% | 1K 150% | 1K - | -44K - | ||||||
net change in cash | -15.25M - | -3.30M 78.38% | 35.11M 1,164.52% | -18.28M 152.06% | -8.40M 54.02% | -4.82M 42.70% | -3.13M 35.08% | 823K 126.33% | -1.38M 267.92% | -3.73M 169.75% | 56K 101.50% | |
cash at beginning of period | 26.39M - | 11.14M 57.79% | 7.84M 29.60% | 42.95M 447.63% | 24.68M 42.55% | 16.27M 34.05% | 11.46M 29.59% | 8.33M 27.28% | 9.15M 9.88% | 7.77M 15.10% | 4.04M 47.97% | |
cash at end of period | 11.14M - | 7.84M 29.60% | 42.95M 447.63% | 24.68M 42.55% | 16.27M 34.05% | 11.46M 29.59% | 8.33M 27.28% | 9.15M 9.88% | 7.77M 15.10% | 4.04M 47.97% | 4.10M 1.38% | |
operating cash flow | -14.49M - | -3.30M 77.21% | -13.71M 315.11% | -19.20M 40.01% | -9.09M 52.64% | -6.00M 34.00% | -3.95M 34.18% | -599K 84.84% | -6.69M 1,017.20% | -3.36M 49.81% | -3.70M 10.15% | |
capital expenditure | -8K - | -3K 62.50% | -171K 5,600% | -5K 97.08% | -213K 4,160% | -23K 89.20% | -148K - | -166K 12.16% | -175K 5.42% | |||
free cash flow | -14.50M - | -3.31M 77.20% | -13.88M 319.90% | -19.20M 38.32% | -9.30M 51.54% | -6.02M 35.26% | -3.95M 34.43% | -747K 81.09% | -6.86M 818.07% | -3.53M 48.47% | -3.70M 4.70% |
All numbers in EUR (except ratios and percentages)